RET and medullary thyroid gland carcinoma: Despite the association between MTC and the MEN2 and the advice that testing for RET proto-oncogene variants is recommended, particularly in young patients, an association between age and a MEN2 diagnosis was not evident, possibly because of a lack of access to genetic screening in some countries and the small size of this sample of reported AMH patients (41, 42).